These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8920706)

  • 1. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
    Lanata CF; Black RE; Flores J; Lazo F; Butron B; Linares A; Huapaya A; Ventura G; Gil A; Kapikian AZ
    Vaccine; 1996 Feb; 14(3):237-43. PubMed ID: 8920706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
    Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
    Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru.
    Lanata CF; Midthun K; Black RE; Butron B; Huapaya A; Penny ME; Ventura G; Gil A; Jett-Goheen M; Davidson BL
    J Infect Dis; 1996 Aug; 174(2):268-75. PubMed ID: 8699054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus vaccines and vaccination in Latin America.
    Linhares AC; Bresee JS
    Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea.
    Linhares AC; Lanata CF; Hausdorff WP; Gabbay YB; Black RE
    Pediatr Infect Dis J; 1999 Nov; 18(11):1001-6. PubMed ID: 10571438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetravalent human-rhesus reassortant rotavirus vaccine: a review of its immunogenicity, tolerability and protective efficacy against paediatric rotavirus gastroenteritis.
    Foster RH; Wagstaff AJ
    BioDrugs; 1998 Feb; 9(2):155-78. PubMed ID: 18020551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
    Joensuu J; Koskenniemi E; Pang XL; Vesikari T
    Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
    Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
    JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations.
    Santosham M; Moulton LH; Reid R; Croll J; Weatherholt R; Ward R; Forro J; Zito E; Mack M; Brenneman G; Davidson BL
    J Pediatr; 1997 Oct; 131(4):632-8. PubMed ID: 9386673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
    Pérez-Schael I; Guntiñas MJ; Pérez M; Pagone V; Rojas AM; González R; Cunto W; Hoshino Y; Kapikian AZ
    N Engl J Med; 1997 Oct; 337(17):1181-7. PubMed ID: 9337376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.
    Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM
    Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.
    Vesikari T; Varis T; Green K; Flores J; Kapikian AZ
    Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Wasserman SS; Glass RI; Keane VA
    Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine.
    Perez-Schael I; Garcia D; Gonzalez M; Gonzalez R; Daoud N; Perez M; Cunto W; Kapikian AZ; Flores J
    J Med Virol; 1990 Mar; 30(3):219-29. PubMed ID: 2160516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field trial of rhesus rotavirus vaccine in infants.
    Christy C; Madore HP; Pichichero ME; Gala C; Pincus P; Vosefski D; Hoshino Y; Kapikian A; Dolin R
    Pediatr Infect Dis J; 1988 Sep; 7(9):645-50. PubMed ID: 2845349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.
    Salinas B; Pérez Schael I; Linhares AC; Ruiz Palacios GM; Guerrero ML; Yarzábal JP; Cervantes Y; Costa Clemens S; Damaso S; Hardt K; De Vos B
    Pediatr Infect Dis J; 2005 Sep; 24(9):807-16. PubMed ID: 16148848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus G serotypes and p[],G genotypes identified in cases of reinfection among children participating in a trial with rhesus-human reassortant tetravalent vaccine (RRV-TV) in Belém, Brazil.
    Mascarenhas JD; Leite JP; Gabbay YB; Freitas RB; Oliveira CS; Monteiro TA; Linhares AC
    J Trop Pediatr; 2002 Apr; 48(2):93-7. PubMed ID: 12022436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
    Rennels MB; Glass RI; Dennehy PH; Bernstein DI; Pichichero ME; Zito ET; Mack ME; Davidson BL; Kapikian AZ
    Pediatrics; 1996 Jan; 97(1):7-13. PubMed ID: 8545227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.